Plus Therapeutics

Plus Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$2.90-$23.42
Market Cap
$26.6M
Shares Short
709,382

Financials

See more
Revenue (12 Mos)
$5.1M
Revenue Growth (YoY)
-2.9%
Gross Profit (12 Mos)
-$4.3M
Diluted EPS
$21.56

News

See more

Yahoo Finance • 16 days ago

Plus Therapeutics Rebranded As Cerenome With Focus Shift To CNS Oncology; 'CNSY' New Trading Symbol

Yahoo Finance • 22 days ago

Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference

Yahoo Finance • 29 days ago

Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Yahoo Finance • last month

Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform

About

CEO
Dr. Marc H. Hedrick M.B.A., M.D.
CFO
Mr. Andrew J. Sims CPA
Address
6420 LEVIT GREEN BOULEVARD, Houston, TX, United States, 77021
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
28